Log in
OTCMKTS:BSTG

Biostage Stock Forecast, Price & News

$1.55
+0.05 (+3.33 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.49
Now: $1.55
$1.70
50-Day Range
$1.17
MA: $1.84
$2.89
52-Week Range
$0.80
Now: $1.55
$4.88
Volume1,585 shs
Average Volume4,180 shs
Market Capitalization$13.75 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.29
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants. It is developing bioengineered organ implants, which addresses the damage of the esophagus, bronchus, and trachea due to cancer, infection, trauma, or congenital abnormalities. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BSTG
CUSIPN/A
Phone774-233-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.13 per share

Profitability

Net Income$-8,330,000.00

Miscellaneous

Employees15
Market Cap$13.75 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$1.55
+0.05 (+3.33 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BSTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Biostage (OTCMKTS:BSTG) Frequently Asked Questions

How has Biostage's stock been impacted by Coronavirus (COVID-19)?

Biostage's stock was trading at $3.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BSTG stock has decreased by 55.7% and is now trading at $1.55.
View which stocks have been most impacted by COVID-19
.

When is Biostage's next earnings date?

Biostage is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Biostage
.

How were Biostage's earnings last quarter?

Biostage Inc (OTCMKTS:BSTG) posted its earnings results on Thursday, August, 13th. The company reported ($0.14) earnings per share for the quarter.
View Biostage's earnings history
.

Who are some of Biostage's key competitors?

What other stocks do shareholders of Biostage own?

Who are Biostage's key executives?

Biostage's management team includes the following people:
  • Mr. James J. McGorry, CEO & Director (Age 63)
  • Mr. Thomas W. McNaughton, CFO & Sec. (Age 59)
  • Yu Hong, Pres (Age 46)
  • Ms. Ginger A. Abraham-Freel, Director of Quality & Operations
  • Dr. William L. Fodor Ph.D., Chief Scientific Officer (Age 60)

What is Biostage's stock symbol?

Biostage trades on the OTCMKTS under the ticker symbol "BSTG."

How do I buy shares of Biostage?

Shares of BSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Biostage's stock price today?

One share of BSTG stock can currently be purchased for approximately $1.55.

How big of a company is Biostage?

Biostage has a market capitalization of $13.75 million. Biostage employs 15 workers across the globe.

What is Biostage's official website?

The official website for Biostage is www.biostage.com.

How can I contact Biostage?

Biostage's mailing address is 84 October Hill Road Suite 11, Holliston MA, 01746. The company can be reached via phone at 774-233-7300 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.